The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

Chronic kidney disease (CKD) is a progressive renal disease that causes kidney function to deteriorate. It appears as urinary ...

A retired Chicago firefighter who was honored by the state for the lives he saved during his 30-year career is now in desperate need of a kidney.

Chronic kidney disease has been linked to yo-yo dieting (also known as body-weight cycling) in the general population, which ...

More than 35 million people in the U.S. have chronic kidney disease (CKD), a condition in which the kidneys are damaged and ...

Body-weight cycling (also known as yo-yo dieting) has been shown to significantly increase the risk of kidney disease in ...

The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.

Former Health Minister and researcher on chronic kidney disease in agricultural communities Dr. Channa Jayasumana, participated as the Chief Guest of the Ramlila Festival held at Bargarh district, ...

A recent modeling study has identified risk factors predictive of good and bad outcomes in non-diabetic CKD, such as gender, ...

The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...

The burden is particularly high in urban areas, where the prevalence reaches 15.2 percent compared to just 2.0 percent in ...

Dialysis Centers used data from the Centers for Disease Control and Prevention to examine the prevalence of chronic diseases ...